Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32445Active, not recruiting
Randomised, double-blind trial of dronabinol (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Resting-state network activity, Cerebral blood flow by arterial spin labeling and 10 more. Started Jan 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32445.